Geneticist pleads guilty to misdemeanor in "art bioterror" case

Robert Ferrell, a geneticist at the University of Pittsburgh who was linkurl:indicted;http://www.the-scientist.com/article/display/22260/ in June, 2004, along with Steven Kurtz, an artist at the State University of New York in Buffalo, after Ferrell shipped bacteria to Kurtz to use in an art project, pled guilty yesterday to charges of "mailing an injurious article," according a linkurl:report;http://www.newsday.com/news/local/wire/newyork/ny-bc-ny--artvsterror1011oct11,0,7989955.story by the AP

Written byAlla Katsnelson
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
Robert Ferrell, a geneticist at the University of Pittsburgh who was linkurl:indicted;http://www.the-scientist.com/article/display/22260/ in June, 2004, along with Steven Kurtz, an artist at the State University of New York in Buffalo, after Ferrell shipped bacteria to Kurtz to use in an art project, pled guilty yesterday to charges of "mailing an injurious article," according a linkurl:report;http://www.newsday.com/news/local/wire/newyork/ny-bc-ny--artvsterror1011oct11,0,7989955.story by the AP. The men were originally charged with mail and wire fraud in connection with Ferrell's purchase of samples of two common bacteria, Serratia marcescens and Bacillus atrophaeus, for Kurtz to use in his biotechnology-related art projects. That charge carries a maximum penalty of 20 years in prison under the Patriot Act -- both originally pled not guilty. Ferrell, 64, who has non-Hodgkins lymphoma and has suffered three strokes since the case began, agreed to the lesser charge to avoid prolonging the case, according to a statement issued by his family yesterday. "I remain unable to wrap my mind around the absurdity of the government's pursuit of this case and I am saddened that it has been dragged out to the point where my dad opted to settle from pure exhaustion," wrote his daughter, Gentry Farrell.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies